Lumasiran Sodium-impurities | Pharmaffiliates

Lumasiran Sodium

Lumasiran Sodium, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1). Reference standards of Lumasiran Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Lumasiran Sodium - API Standards 
    [catalogue_number] => PA 12 1890000
    [category_ids] => ,76,78,70,82,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => 1834612-06-4
    [pslug] => 1834612-06-4-lumasiran-sodium-api-pa121890000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Lumasiran Sodium - API Standards


  • Catalogue No.:PA 12 1890000

  • CAS :

    1834612-06-4

  • Molecular Formula : NA

  • Molecular Weight : NA